DSA BreathPass™ is a handheld breath analyzing device intended for the detection of COVID-19.
The average time to take a sample is 15 seconds and the diagnosis is available in 3 seconds.
The system is ready for a new person every 2 minutes.
The average time to take a sample is 15 seconds and the diagnosis is available in 3 seconds.
The system is ready for a new person every 2 minutes.
|
|
How does it work?
|
The unit contains a set of carefully selected and configured nanosensors that record Volatile Organic Compounds (VOC) and other substances connected to the biomarkers to be identified in exhaled breath gas. The biomarker VOC’s are born in human metabolism and their known relation – the VOC profile – with a given disease forms the basis for the analysis.
DSA BreathPass™ communicates with an Artificial Intelligence based cloud algorithm to calculate how well the measured breathprint of the individual’s VOC profile matches with the known COVID-19 features. The results are available immediately. DSA BreathPass™ and future development versions will be brought available for early detection of diseases such as lung and colon cancers and chronic obstructive pulmonary disease (COPD). |